{"id":"W2150604072","doi":"10.1002/ajh.23728","title":"Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24‐month follow‐up","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; Ariad Pharmaceuticals; Teva Pharmaceutical Industries; Pfizer; Bristol-Myers Squibb","keywords":"Bosutinib; Medicine; Internal medicine; Imatinib; Dasatinib; Nilotinib; Nausea; Adverse effect; Gastroenterology; Myeloid leukemia; Oncology; Rash; Tyrosine-kinase inhibitor; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006342038,0.0004721741,0.002006861,0.0003847487,0.00008580281,0.00002150799,0.0002787989,0.0001625356,0.0003387491],"category_scores_gemma":[0.0005271336,0.000361619,0.000211934,0.0005368192,0.0008703522,0.0001777662,0.00008903295,0.0008053468,0.00003368222],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00388393,"about_ca_system_score_gemma":0.003122926,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000670819,"about_ca_topic_score_gemma":0.00063168,"domain_scores_codex":[0.9963194,0.0003326331,0.001559387,0.0005358709,0.0004300178,0.0008226843],"domain_scores_gemma":[0.9969147,0.0007503263,0.00115166,0.0006057782,0.0001613155,0.0004161946],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1879202,0.002993423,0.05588077,0.003677306,0.003194725,0.01542728,0.01039886,0.0002334712,0.01788925,0.001448985,0.01366753,0.6872681],"study_design_scores_gemma":[0.5152993,0.06958779,0.1111847,0.01488783,0.002555716,0.04740287,0.002835066,0.005838576,0.0150981,0.0006743896,0.2112599,0.003375833],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887447,0.00767126,0.0004797362,0.00156585,0.0003947408,0.0005038772,0.000009873636,0.00003184207,0.0005981077],"genre_scores_gemma":[0.9941012,0.001271137,0.002935883,0.0005138184,0.0003865708,0.00003864191,0.00001010842,0.00006929049,0.0006733194],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6838923,"threshold_uncertainty_score":0.99994,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01050857351669677,"score_gpt":0.2926125195130662,"score_spread":0.2821039459963695,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}